SI2247585T1 - Kristalne oblike N-(2-(dietilamino)etil)-5-(5-fluoro-1,2-dihidro-2-okso-3H-indol-3-iliden metil)-2,4-dimetil-1H-pirol-3-karboksamida in postopki za njihovo pripravo - Google Patents
Kristalne oblike N-(2-(dietilamino)etil)-5-(5-fluoro-1,2-dihidro-2-okso-3H-indol-3-iliden metil)-2,4-dimetil-1H-pirol-3-karboksamida in postopki za njihovo pripravoInfo
- Publication number
- SI2247585T1 SI2247585T1 SI200930926T SI200930926T SI2247585T1 SI 2247585 T1 SI2247585 T1 SI 2247585T1 SI 200930926 T SI200930926 T SI 200930926T SI 200930926 T SI200930926 T SI 200930926T SI 2247585 T1 SI2247585 T1 SI 2247585T1
- Authority
- SI
- Slovenia
- Prior art keywords
- methylć
- ethylć
- ylidene
- indol
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08004143A EP2098521A1 (en) | 2008-03-06 | 2008-03-06 | Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation |
EP09717772.9A EP2247585B1 (en) | 2008-03-06 | 2009-03-05 | Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
PCT/EP2009/001568 WO2009109388A1 (en) | 2008-03-06 | 2009-03-05 | Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2247585T1 true SI2247585T1 (sl) | 2014-08-29 |
Family
ID=39590734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200930926T SI2247585T1 (sl) | 2008-03-06 | 2009-03-05 | Kristalne oblike N-(2-(dietilamino)etil)-5-(5-fluoro-1,2-dihidro-2-okso-3H-indol-3-iliden metil)-2,4-dimetil-1H-pirol-3-karboksamida in postopki za njihovo pripravo |
Country Status (15)
Country | Link |
---|---|
US (1) | US20110034703A1 (sl) |
EP (3) | EP2098521A1 (sl) |
JP (1) | JP2011513349A (sl) |
KR (1) | KR101604501B1 (sl) |
CN (1) | CN101965342B (sl) |
AU (1) | AU2009221458A1 (sl) |
CA (1) | CA2714441A1 (sl) |
EA (1) | EA020067B1 (sl) |
ES (1) | ES2478821T3 (sl) |
IL (1) | IL207984A (sl) |
PL (1) | PL2247585T3 (sl) |
PT (1) | PT2247585E (sl) |
SI (1) | SI2247585T1 (sl) |
WO (1) | WO2009109388A1 (sl) |
ZA (1) | ZA201005796B (sl) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009067674A2 (en) * | 2007-11-21 | 2009-05-28 | Teva Pharmaceutical Industries Ltd. | Polymorphs of sunitinib base and processes for preparation thereof |
EP2280960A1 (en) * | 2008-04-16 | 2011-02-09 | Natco Pharma Limited | Novel polymorphic forms of sunitinib base |
US8153678B2 (en) | 2008-06-13 | 2012-04-10 | Medichem, S.A. | Process for preparing A 3-pyrrole substituted 2-indolinone malate salt |
CN102197034A (zh) * | 2008-08-25 | 2011-09-21 | 基因里克斯(英国)有限公司 | 舒尼替尼的新型多晶型物及其制备方法 |
EP2315764A2 (en) * | 2008-08-25 | 2011-05-04 | Generics [UK] Limited | Crystalline form of sunitinib and processes for its preparation |
AU2011210327A1 (en) | 2010-01-29 | 2012-08-23 | Ranbaxy Laboratories Limited | Crystalline forms of L-malic acid salt of sunitinib |
WO2011100325A2 (en) | 2010-02-09 | 2011-08-18 | Sicor Inc. | Polymorphs of sunitinib salts |
US20150174096A1 (en) * | 2012-06-12 | 2015-06-25 | Bayer Healthcare Llc | Topical ophthalmological pharmaceutical composition containing sunitinib |
CN103833733B (zh) * | 2012-11-21 | 2017-08-25 | 广东东阳光药业有限公司 | 一种替尼类药物新晶型 |
ES2813877T3 (es) | 2013-08-28 | 2021-03-25 | Crown Bioscience Inc Taicang | Distintivos de expresión génica predictivos de la respuesta de un sujeto a un inhibidor multicinasa y métodos de uso de los mismos |
RU2567535C1 (ru) * | 2014-10-01 | 2015-11-10 | Олег Ростиславович Михайлов | КРИСТАЛЛИЧЕСКАЯ ε-МОДИФИКАЦИЯ N-[2-(ДИЭТИЛАМИНО)ЭТИЛ]-5-[(Z)-(5-ФТОР-1,2-ДИГИДРО-2-ОКСО-3Н-ИНДОЛ-3-ИЛИДЕН)МЕТИЛ]-2,4-ДИМЕТИЛ-1Н-ПИРРОЛ-3-КАРБОКСАМИД МАЛАТА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЕ ОСНОВЕ |
CN106884206A (zh) * | 2017-03-17 | 2017-06-23 | 青岛大学 | 一种有机非线性光学晶体用籽晶的生长方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU784266B2 (en) | 1999-12-22 | 2006-03-02 | Sugen, Inc. | Indolinone derivatives for modulation of c-kit tyrosine kinase |
ES2290117T3 (es) * | 2000-02-15 | 2008-02-16 | Sugen, Inc. | Inhibidores de proteina quinasa 2-indolina sustituida con pirrol. |
EP3168218B1 (en) * | 2001-08-15 | 2018-11-14 | Pharmacia & Upjohn Company LLC | A crystal comprising an l-malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide for use as a medicament |
TWI259081B (en) | 2001-10-26 | 2006-08-01 | Sugen Inc | Treatment of acute myeloid leukemia with indolinone compounds |
AU2003216282A1 (en) * | 2002-02-15 | 2003-09-09 | Pharmacia And Upjohn Company Llc | Process for preparing indolinone derivatives |
-
2008
- 2008-03-06 EP EP08004143A patent/EP2098521A1/en not_active Withdrawn
-
2009
- 2009-03-05 EA EA201001243A patent/EA020067B1/ru not_active IP Right Cessation
- 2009-03-05 PT PT97177729T patent/PT2247585E/pt unknown
- 2009-03-05 KR KR1020107019864A patent/KR101604501B1/ko active IP Right Grant
- 2009-03-05 CN CN200980107316.8A patent/CN101965342B/zh not_active Expired - Fee Related
- 2009-03-05 EP EP09717772.9A patent/EP2247585B1/en active Active
- 2009-03-05 AU AU2009221458A patent/AU2009221458A1/en not_active Abandoned
- 2009-03-05 SI SI200930926T patent/SI2247585T1/sl unknown
- 2009-03-05 JP JP2010549060A patent/JP2011513349A/ja active Pending
- 2009-03-05 ES ES09717772.9T patent/ES2478821T3/es active Active
- 2009-03-05 CA CA2714441A patent/CA2714441A1/en not_active Abandoned
- 2009-03-05 US US12/918,612 patent/US20110034703A1/en not_active Abandoned
- 2009-03-05 WO PCT/EP2009/001568 patent/WO2009109388A1/en active Application Filing
- 2009-03-05 PL PL09717772T patent/PL2247585T3/pl unknown
- 2009-03-05 EP EP13158832.9A patent/EP2604603A1/en not_active Withdrawn
-
2010
- 2010-08-13 ZA ZA2010/05796A patent/ZA201005796B/en unknown
- 2010-09-05 IL IL207984A patent/IL207984A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2714441A1 (en) | 2009-09-11 |
IL207984A0 (en) | 2010-12-30 |
EA201001243A1 (ru) | 2011-04-29 |
EP2098521A1 (en) | 2009-09-09 |
AU2009221458A1 (en) | 2009-09-11 |
WO2009109388A8 (en) | 2010-10-07 |
JP2011513349A (ja) | 2011-04-28 |
CN101965342A (zh) | 2011-02-02 |
EP2247585B1 (en) | 2014-04-30 |
PT2247585E (pt) | 2014-07-17 |
PL2247585T3 (pl) | 2014-09-30 |
US20110034703A1 (en) | 2011-02-10 |
ZA201005796B (en) | 2011-04-28 |
EP2247585A1 (en) | 2010-11-10 |
EP2604603A1 (en) | 2013-06-19 |
WO2009109388A1 (en) | 2009-09-11 |
EA020067B1 (ru) | 2014-08-29 |
IL207984A (en) | 2016-07-31 |
ES2478821T3 (es) | 2014-07-23 |
KR20100125300A (ko) | 2010-11-30 |
KR101604501B1 (ko) | 2016-03-17 |
CN101965342B (zh) | 2014-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2247585T1 (sl) | Kristalne oblike N-(2-(dietilamino)etil)-5-(5-fluoro-1,2-dihidro-2-okso-3H-indol-3-iliden metil)-2,4-dimetil-1H-pirol-3-karboksamida in postopki za njihovo pripravo | |
IL248723B (en) | Specific antibodies against the bcr complex and methods of using them | |
HK1144248A1 (zh) | -特定抗體及其使用方法 | |
GB2488684B (en) | Input/output architecture for mounted processors, and methods of using same | |
HK1150603A1 (en) | Crystalline forms of dimethoxy docetaxel and methods for preparing same | |
EP2347336A4 (en) | METHOD AND SYSTEM FOR SECURE USE OF SERVICES BY UNSECURED STORAGE SUPPLIERS | |
EP2328934A4 (en) | T cell Receptor Antibodies and Method of Use | |
EP2299915A4 (en) | ANCHORS AND METHODS OF FIXING SUTURE TO BONE | |
DK2358669T3 (da) | Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf | |
IL207100A0 (en) | 2-amino-quinoline derivatives useful as inhibitors of b-secretase (bace) | |
IL208939A0 (en) | 5-ht3 receptor modulators, methods of making, and use thereof | |
EP2111463A4 (en) | METHOD AND DEVICES FOR DIAGNOSIS OF BLIND DARM TONGUE | |
EP2139322A4 (en) | INDOLE CARBOXAMIDES AS INHIBITORS OF IKK2 | |
EP2297332A4 (en) | METHODS AND PLATFORMS FOR DISCOVERING MEDICINES | |
AP2743A (en) | Macrocyclic indole derivatives useful as hepatitisC virus inhibitors | |
EP2533464A4 (en) | METHOD AND SYSTEM FOR SUBSCRIBING SERVICES OVER ADVANCED UPNP STANDARD AND WET TISPAN AUTHENTICATION | |
EP2257316A4 (en) | CONTRAST AGENTS, METHODS FOR PREPARING CONTRAST AGENTS, AND IMAGING METHODS | |
EP2141160A4 (en) | GROUND CRYSTAL OLMESARTAN MEDOXOMIL | |
AP2774A (en) | Substituted (pyrazolylcarbonyl) imidazolidinones and their uses | |
IL209718A0 (en) | Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof | |
PL2274303T3 (pl) | Sposoby otrzymywania sunitynibu i jego soli | |
IL213389B (en) | Preparations, methods and uses of polyoxyethylene polymer for inducing viral growth | |
ZA201008139B (en) | Means for fixing of screening media,and use of such means | |
EP2482659A4 (en) | HEXAHYDROCYCLOPENTA [F] INDAZOLE 5-YLE ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS | |
EP2267196A4 (en) | ALN CRYSTAL GROWTH METHOD AND ALN LAMINATE |